02.12.2014 Views

Innovation in European healthcare – what can Sweden learn? - LIF

Innovation in European healthcare – what can Sweden learn? - LIF

Innovation in European healthcare – what can Sweden learn? - LIF

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

NHS hospitals are reimbursed for services through a<br />

scheme known as Payment by Results’ (PbR)<br />

• Payment by Results (PbR) is the national tariff system by which hospitals and providers are reimbursed for<br />

their activity.<br />

• The ma<strong>in</strong> currency of <strong>healthcare</strong> activity l<strong>in</strong>ked to PbR is the Healthcare Resource Group (HRG).<br />

• An HRG is essentially a case-mix group<strong>in</strong>g of different patient diagnosis and treatment procedures<br />

clustered because they are known to consume similar types of resources.<br />

• Medical <strong>in</strong>tervention and patient diagnoses are classified based on the OPCS-4 and ICD-10 classification<br />

systems. The data is grouped and coded <strong>in</strong>to Health Resource Groups (HRGs).<br />

• These resources also factor <strong>in</strong> non-cl<strong>in</strong>ical costs such as food, clean<strong>in</strong>g, and estate costs, all of which may<br />

be utilised between a patient’s period of admission to discharge.<br />

• The price for standard cl<strong>in</strong>ical procedures is known as the ‘reference costs’, which are national average<br />

costs throughout the NHS. Tariffs are adjusted for long/short hospital stays, cl<strong>in</strong>ical best practices,<br />

specialised care, and market forces for geographical variation.<br />

• PbR has cont<strong>in</strong>ued to expand <strong>in</strong> scope s<strong>in</strong>ce its establishment. At its start it only covered about £100 million<br />

of activity, ma<strong>in</strong>ly <strong>in</strong> elective procedures, with plans to cover as much secondary care expenditure as<br />

possible –about £60 billion. Primary care expenditure for GPs, dentists, opticians, and prescrib<strong>in</strong>g (about<br />

£20 billion) have thus far been covered by national contract<strong>in</strong>g and fund<strong>in</strong>g arrangements.<br />

• PbR <strong>can</strong> be flexible and allow for deviation from tariff rules. For example, ‘<strong>in</strong>novation payments’ give<br />

commissioners flexibility <strong>in</strong> pay<strong>in</strong>g for a new drug or device which gives better care than <strong>in</strong> the tariff.<br />

128

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!